Pregnancy thyroid screening
Eleven percent of pregnant Indian women have hypothyroidism. That is 1 in 9. Most are undiagnosed. Most OBs never test. Most women never know their thyroid is broken until their baby is born with developmental delays, or they miscarry, or they deliver prematurely. This is preventable. A single TSH test at first antenatal visit costs less than 500 rupees. It takes 5 minutes. It can save the entire pregnancy.
The thyroid produces hormones (T3, T4) that regulate every metabolic cell in your body — your heart rate, body temperature, energy, mood, fertility, and fetal brain development. In pregnancy, your fetus depends entirely on your thyroid hormones to build its brain, nervous system, and bones. If your thyroid is failing, your baby's development fails. This is not theoretical. It is measurable neurodevelopmental impairment.
Uncontrolled hypothyroidism in pregnancy causes:
This is why early diagnosis and treatment is non-negotiable. Waiting until T2 or T3 to start levothyroxine leaves critical windows of fetal brain development unprotected.
In early pregnancy, the developing placenta (trophoblast) produces hCG (human chorionic gonadotropin). hCG shares structural homology with TSH and binds weakly to TSH receptors on the thyroid. Result: mild thyroid hormone elevation and TSH suppression. This is usually benign and transient — TSH often "bounces back" to normal by T2 as hCG declines. However, in women with borderline thyroid reserve, hCG stimulation can unmask latent hypothyroidism, manifesting as elevated TSH by mid-pregnancy.
Estrogen in pregnancy stimulates hepatic TBG production. TBG binds thyroid hormones in blood, transporting them. Higher TBG means more total T4 and T3 are bound, but less is free (biologically active). To maintain adequate free hormone, your thyroid must produce more. If your thyroid is already struggling, it cannot keep pace. Result: progressive TSH elevation and insufficiency despite "normal" total T4.
Pregnancy increases glomerular filtration rate by 50%. Iodine is filtered aggressively by the kidneys. Simultaneously, your fetus demands iodine to synthesize its own thyroid hormones (from 12 weeks gestation onward). The net result: iodine requirements increase 25-50% in pregnancy. If your iodine status was marginal before pregnancy, it will become deficient during. This is particularly relevant in India, where iodization is improving but variable by region.
Combine all three: hCG stimulation (T1) + increased TBG (all trimesters) + increased iodine demands (all trimesters) = thyroid stress on top of pre-existing deficiency. A woman with subclinical hypothyroidism (TSH mildly elevated but free T4 normal) before pregnancy will often decompensate into overt hypothyroidism during pregnancy.
Standard TSH "normal" is 0.5-5.0 mIU/L. This is wrong in pregnancy. The American Thyroid Association (ATA) recommends trimester-specific cutoffs because TSH naturally suppresses in early pregnancy due to hCG:
However, Indian data suggests even tighter cutoffs are prudent: upper limit of 3.0 in T1 and 3.5 in T2/T3 should be used for screening and treatment initiation. This is more conservative but aligns with observed adverse outcomes.
If you use non-pregnant cutoffs (TSH <5.0 is "okay") in pregnancy, you will miss subclinical hypothyroidism in 5-10% of pregnant women. Those women will have increased miscarriage, preterm birth, and neurodevelopmental impairment. This is a screening failure, not a medical mystery.
Subclinical hypothyroidism means elevated TSH with normal free T4. It affects 9.51% of pregnant Indian women. No obvious symptoms. Blood pressure normal. No fatigue. The OB says "TSH is a bit high but T4 is fine, don't worry."
Don't believe it. Even subclinical hypothyroidism is linked to:
Many randomized trials show that treating subclinical hypothyroidism in pregnancy reduces these risks. Yet many Indian OBs ignore it. Reason: they learned "TSH <10 is not a problem" from outdated guidelines. This is wrong in pregnancy.
arq.'s approach: We treat all TSH >3.0 in T1 and >3.5 in T2/T3, even with normal free T4, with levothyroxine. Dose: typically 25-50 mcg daily, titrated every 6-8 weeks based on TSH. Target: keep TSH <2.5-3.0 throughout pregnancy.
Overt hypothyroidism means elevated TSH (often >10) with low or normal free T4. It is symptomatic: fatigue, weight gain, cold intolerance, constipation, hair loss, depression. It is more common than you think — 2.74% of pregnant Indian women have it. Most are undiagnosed until late pregnancy, missing critical windows.
Diagnosis: TSH + free T4 (not total T4, which is misleading due to elevated TBG). If TSH >10 and free T4 low-normal or low, treat immediately.
Treatment: Levothyroxine (synthetic T4). Dose depends on severity and prepregnancy baseline. Most women start 50-100 mcg daily, with adjustments every 6-8 weeks.
Why not combination T3+T4? Desiccated thyroid (NDT) and liothyronine (T3) are not recommended in pregnancy. Levothyroxine monotherapy allows precise TSH control and is safest.
Hyperthyroidism in pregnancy (Graves' disease, toxic nodules) affects 1.25% of pregnant Indian women. It carries different risks than hypothyroidism: maternal tachycardia, atrial fibrillation, miscarriage, preterm birth, intrauterine growth restriction, and fetal hyperthyroidism (if TSI antibodies cross the placenta).
Mild TSH suppression with normal free T4 in early pregnancy (due to hCG stimulation) is usually benign and transient. TSH <0.01 with free T4 in upper normal range typically requires no treatment. However, if free T4 is elevated or TSH remains suppressed into T2, antithyroid therapy may be needed. PTU (propylthiouracil) is preferred over methimazole in T1 due to lower risk of methimazole embryopathy (rare but real: aplasia cutis, esophageal atresia). Switch to methimazole in T2/T3 due to PTU's rare hepatotoxicity.
TPO (thyroid peroxidase) antibodies indicate autoimmune thyroiditis. Many women have elevated TPO but normal TSH. Standard practice: "Don't treat, just monitor." This is wrong in pregnancy.
Data is clear: TPO-positive women without treatment have 2-3x higher miscarriage rates even if TSH is normal. Mechanism: autoimmune inflammation damages the placenta, impairing invasion and fetal tolerance. Some antibodies may directly target placental tissue.
Management options:
At minimum, all TPO-positive women should be monitored closely and treated if TSH rises above 2.5.
Should all pregnant Indian women be screened for thyroid disease, or only those with symptoms/risk factors?
Answer: Universal screening is absolutely necessary in India.
Reason: 11% prevalence. That is far higher than in Western countries (2-5%) and justifies population-level screening. Selective screening (only symptomatic women) misses 90% of cases. By the time symptoms appear, fetal brain development has already been compromised. The cost of universal TSH screening is trivial (<500 rupees); the benefit is preventing miscarriage, preterm birth, and lifelong neurodevelopmental impairment. American Thyroid Association recommends universal screening in all countries. India should follow suit.
Practical implementation: TSH + free T4 at first antenatal visit. Repeat every 6-8 weeks if on levothyroxine, or at 12 weeks if baseline TSH was normal. If TSH elevated, treat immediately.
Levothyroxine requirements increase 25-50% during pregnancy in women already on it, and even higher in newly diagnosed women. Why?
A woman on 50 mcg before pregnancy may need 75 mcg in T1, 100 mcg in T2/T3. A woman on 100 mcg may need 150 mcg. Some need 75% increase.
Pre-pregnancy or pre-conception: If already on levothyroxine, increase dose by 25-30% immediately upon positive pregnancy test. Do not wait for TSH to rise.
Newly diagnosed hypothyroidism: Start 50 mcg daily if TSH 4-10; start 75-100 mcg if TSH >10. Increase every 6-8 weeks by 25 mcg increments until TSH is in target range.
Monitoring: Check TSH every 6-8 weeks during pregnancy. Adjust dose to keep TSH <2.5-3.0. Do not rely on symptoms — they are unreliable in pregnancy.
After delivery, levothyroxine requirements usually return to pre-pregnancy levels. Recheck TSH 6-8 weeks postpartum and reduce dose if necessary. Do not continue the higher pregnancy dose indefinitely or you risk iatrogenic hyperthyroidism.
Postpartum thyroiditis affects 5-10% of women (higher in iodine-sufficient regions like India). It is autoimmune inflammation triggered by abrupt postpartum immune reconstitution. Women with TPO antibodies, prior autoimmune disease, or PCOS are at higher risk.
Clinical course (typically biphasic):
Some women have only one phase. Some skip the hyperthyroid phase entirely.
Diagnosis: TSH + free T4 at 6 weeks postpartum if symptomatic. Many cases are missed because symptoms overlap with postpartum mood disorder and sleep deprivation.
Treatment: In hyperthyroid phase, beta-blockers (propranolol) for symptom relief; no antithyroid medication needed (the hyperthyroidism is destructive, not TSH-driven). In hypothyroid phase, levothyroxine as needed. Most women recover spontaneously, but 20-25% develop persistent hypothyroidism requiring long-term levothyroxine.
Internal link: Read more about postpartum recovery and thyroiditis for full postpartum management protocols.
Our approach to thyroid in pregnancy is aggressive by Indian standards, but aligned with international evidence:
Below are ten questions we are asked frequently about thyroid in pregnancy, with physician-reviewed answers.
Thyroid dysfunction in pregnancy affects 12% of Indian women. Untreated hypothyroidism increases miscarriage risk by 60%, preterm birth by 200%, and impairs fetal brain development. TSH should be below 2.5 mIU/L in first trimester (not the standard 4.5 cutoff). Test TSH + Free T4 + TPO antibodies every trimester.
| Parameter | 1st Trimester | 2nd Trimester | 3rd Trimester | Postpartum |
|---|---|---|---|---|
| TSH (mIU/L) | 0.1–2.5 | 0.2–3.0 | 0.3–3.0 | 0.5–5.0 (non-pregnant) |
| Free T4 (pg/mL) | 9.5–18 | 8.5–16 | 8–15 | 9–18 (non-pregnant) |
| TPO Antibodies | Positive = higher miscarriage risk | Monitor; suppress TSH <2.0 | Monitor; suppress TSH <2.5 | Check postpartum (thyroiditis risk) |
| Levothyroxine Dose | Often needs 25–50% increase | Retest TSH every 6–8 weeks | Maintain trimester-specific TSH | Reduce to pre-pregnancy; retest 6–8 wks |
No AI chat. No templates. A specialist reads your panel against South Asian-calibrated ranges and writes the protocol on a 15–20 minute video consult — inside 7 days of your home draw.